Evidence map›Paper›PMID 41629750›Full record

ArticleDiabetes, obesity & metabolism2026

Early detection of type 2 diabetes mellitus-associated cognitive dysfunction: The potential of amide proton transfer-weighted imaging.

Ju-Wei Shao, Ying Yang, Yun-Qian Zhang, Hong-Yan Dai, Jing Fang, Thomas C Booth

Abstract read
In one paragraph

Article in Diabetes, obesity & metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ju-Wei ShaoDepartment of Radiology, The Affiliated Hospital of Yunnan University, Kunming, Yunnan, China.ORCID 0000-0002-2271-1677
Ying YangDepartment of Endocrinolgy, The Affiliated Hospital of Yunnan University, Kunming, Yunnan, China.
Yun-Qian ZhangDepartment of Neurology, The Affiliated Hospital of Yunnan University, Kunming, Yunnan, China.
Hong-Yan DaiDepartment of Radiology, The Affiliated Hospital of Yunnan University, Kunming, Yunnan, China.
Jing FangInstitute for Health Sciences, Kunming Medical University, Kunming, Yunnan, China.
Thomas C BoothSchool of Biomedical Engineering & Imaging Sciences, King's College London, London, UK.

Funding

MRC DPFS MR/W021684/1STAR Special Fund for Medical Imaging Research YN-2022-S-01Wellcome/Engineering and Physical Sciences Research Council Centre for Medical Engineering WT203148/Z/16/ZYunnan Provincial Department of Science and Technology - Kunming Medical University Joint Special Project 202301AY070001-230Yunnan University Medical Research Fund YDYXJJ2024-0012
6 · The paper itself

Abstract

aimsType 2 diabetes mellitus (T2DM) may lead to diabetes-associated cognitive dysfunction (DACD). We aimed to develop an amide proton transfer-weighted (APTw) magnetic resonance imaging (MRI) biomarker to assist early identification of T2DM with DACD. MATERIALS AND

methodsThe study included 27 T2DM patients, comprising 19 with mild cognitive impairment (T2DM-MCI) and 8 without (T2DM-nMCI), along with 11 community-based controls without MCI (CG-nMCI). All participants completed neuropsychological tests and APTw-MRI. We measured hippocampal APTw signal intensity (SI) in both groups, analysed its correlation with cognitive scores and assessed diagnostic performance using area under the curve (AUC).

resultsIn T2DM-nMCI patients, left hippocampal head APTw SI showed a positive correlation with semantic verbal fluency (SVF; r = 0.770, R

conclusionsAPTw imaging suggested a spatially evolving pattern of hippocampal damage in T2DM, where the left body may show early alterations, with the left head potentially becoming more implicated upon MCI onset. These findings provide preliminary evidence supporting the potential of APTw as an early, non-invasive biomarker for tracking neuropathological progression in DACD.

Indexed as

Cognitive DysfunctionDiabetes Mellitus, Type 2Magnetic Resonance ImagingAgedAmidesBiomarkersCase-Control StudiesEarly DiagnosisFemaleHippocampusHumansMaleMiddle AgedNeuropsychological TestsProtonsAmidesBiomarkersProtonsamide proton transfer‐weighteddiabetes‐associated cognitive dysfunctionmagnetic resonance imagingmild cognitive impairmenttype 2 diabetes mellitus

Identifiers

PMID41629750
PMCPMC12992161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.